33 related articles for article (PubMed ID: 36878305)
1. Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry.
Angel PM; Bruner E; Bethard J; Clift CL; Ball L; Drake RR; Feghali-Bostwick C
J Mass Spectrom; 2020 Apr; 55(4):e4450. PubMed ID: 31654589
[TBL] [Abstract][Full Text] [Related]
2. Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor.
Furuhashi S; Morita Y; Matsumoto A; Ida S; Muraki R; Kitajima R; Takeda M; Kikuchi H; Hiramatsu Y; Takeuchi H
Am J Cancer Res; 2023; 13(11):5641-5655. PubMed ID: 38058842
[TBL] [Abstract][Full Text] [Related]
3. Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.
Gschwandtner M; Gammage AN; Deligne C; Mies LFM; Domaingo A; Murdamoothoo D; Loustau T; Schwenzer A; Derler R; Carapito R; Koch M; Mörgelin M; Orend G; Kungl AJ; Midwood KS
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176074
[TBL] [Abstract][Full Text] [Related]
4. Chemokine Binding to Tenascin-C Influences Chemokine-Induced Immune Cell Migration.
Domaingo A; Jokesch P; Schweiger A; Gschwandtner M; Gerlza T; Koch M; Midwood KS; Kungl AJ
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834140
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Tenascin C levels in the serum of patients with bronchial asthma.
Elgendy A; El-Shayeb M; Hassanein YA; Elkady HM
Egypt J Immunol; 2024 Jan; 31(1):20-29. PubMed ID: 38224032
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Matrix-Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity.
Wu Y; Li Y; Hu Z; Li Y; Zhang S; Bao X; Zhou Y; Gao Y; Li Y; Zhang Z
Adv Mater; 2024 Apr; 36(15):e2310982. PubMed ID: 38216153
[TBL] [Abstract][Full Text] [Related]
7. Clinical advances in TNC delivery vectors and their conjugate agents.
Chen W; Wu Y; Wang J; Yu W; Shen X; Zhao K; Liang B; Hu X; Wang S; Jiang H; Liu X; Zhang M; Xing X; Wang C; Xing D
Pharmacol Ther; 2024 Jan; 253():108577. PubMed ID: 38081519
[TBL] [Abstract][Full Text] [Related]
8. The role of TNC in atherosclerosis and drug development opportunities.
Chen W; Wang Y; Ren C; Yu S; Wang C; Xing J; Xu J; Yan S; Zhang T; Li Q; Peng X; Shao Y; Zhang R; Zhang D; Xing D
Int J Biol Sci; 2024; 20(1):127-136. PubMed ID: 38164188
[TBL] [Abstract][Full Text] [Related]
9. Tenascin C in metastasis: A view from the invasive front.
Lowy CM; Oskarsson T
Cell Adh Migr; 2015; 9(1-2):112-24. PubMed ID: 25738825
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C affects invasiveness of EGFR-mutated lung adenocarcinoma through a putative paracrine loop.
Schlensog M; Ruehlmann AC; Haeberle L; Opitz F; Becher AK; Goering W; Buth J; Knoefel WT; Ladage D; Meyer A; Esposito I
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166684. PubMed ID: 36878305
[TBL] [Abstract][Full Text] [Related]
12. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
Gocheva V; Naba A; Bhutkar A; Guardia T; Miller KM; Li CM; Dayton TL; Sanchez-Rivera FJ; Kim-Kiselak C; Jailkhani N; Winslow MM; Del Rosario A; Hynes RO; Jacks T
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5625-E5634. PubMed ID: 28652369
[TBL] [Abstract][Full Text] [Related]
14. Potential Impacts of
Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
